Elizabeth Nadal, DO
Obstetrics & Gynecology · Westport, CTNPI 1730508946
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,258, 8.4 times the $149 reported in 2019. Among obstetrics & gynecology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 192 payments — averaging $23.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$808
- Exeltis, USA Inc.$723
- Mayne Pharma Commercial LLC$700
- Sumitomo Pharma America, Inc.$287
- Merck$226
- Astellas Pharma US Inc$189
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,40096%
- Education$1864%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 46 | $808 |
| Exeltis, USA Inc. | 14 | $723 |
| Mayne Pharma Commercial LLC | 28 | $700 |
| Sumitomo Pharma America, Inc. | 12 | $287 |
| Merck | 13 | $226 |
| Astellas Pharma US Inc | 5 | $189 |
| Pfizer | 7 | $185 |
| Millicent US Inc | 5 | $181 |
| Therapeuticsmd, Inc. | 10 | $175 |
| Exact Sciences | 8 | $171 |
| Biogen | 6 | $169 |
| Myovant Sciences Inc. | 7 | $133 |
| Organon | 5 | $118 |
| Bayer | 6 | $118 |
| Scynexis, Inc. | 3 | $85 |
| Agile Therapeutics, Inc. | 4 | $80 |
| Medicem Inc. | 2 | $36 |
| Shield Therapeutics Inc | 2 | $33 |
| Avion Pharmaceuticals | 2 | $33 |
| Novo Nordisk | 1 | $25 |
| Aspira Women's Health Inc | 1 | $24 |
| Coopersurgical, Inc. | 1 | $24 |
| Duchesnay USA Incorporated | 1 | $19 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Covidien LP | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Slynd$202
- ANNOVERA$124
- NEXTSTELLIS$124
How this compares
$4,586 in reported general payments places this provider in the 90th percentile of 605 obstetrics & gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 63 | $6,470 |
| ProgesteroneProgesterone, Micronized | 13 | $423 |
| ValacyclovirValacyclovir Hcl | 18 | $373 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Westport
- Adam OferWestport$4K
- Mary MinkinNew Haven$285K
- Alessandro SantinNew Haven$98K
- Frederick RauHartford$89K
- Peter AuerbachGroton$41K
- Shieva GhofranyStamford$33K
- Mark LeondiresNorwalk$31K
- Alan FineHartford$30K
- Sean FlahertyHamden$28K
- Adam SteinbergHartford$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.